<DOC>
	<DOCNO>NCT02448147</DOCNO>
	<brief_summary>BACKGROUND : The physiopathology heart failure involve compensatory mechanism exacerbate neurohormonal activity , endothelial dysfunction consequently muscle disability exercise intolerance . The interval exercise training propose one efficient method heart failure patient . It seem main mechanism involve benefit interval exercise training `` shear stress '' . AIM : To study interval exercise training versus continuous exercise training sympathetic activity peripheral muscle perfusion heart failure patient . Moreover , evaluate muscle apoptosis , microRNA plasma muscle biopsy , biomarkers level inflammation , quality life exercise capacity . METODOLOGY : Will select 40 patient ( male female ) age 30 60 year , leave ventricular ejection fraction le 40 % functional class I , II III . These patient randomize three group : Interval ( AIT ) , continuous ( MCT ) control ( CG ) . All patient evaluate microneurography , peripheral muscle perfusion , muscle biopsy , blood sample , accelerometer , cardiopulmonary exercise test quality life end period 03 ( three ) month .</brief_summary>
	<brief_title>Interval Versus Continuous Training Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>stable chronic heart failure without change treatment least 6 week ejection fraction le 40 % , measure transthoracic echocardiography optimal clinical treatment chronic heart failure accord current guideline . asthma chronic obstructive pulmonary disease use inhaled corticosteroid functional class IV ( New York Heart Association NYHA ) atrial fibrillation complex ventricular arrhythmia pacemaker implantable cardioversor/defibrillators chronic renal insufficiency , define serum creatinine 2,5 mg/dL intermittent claudication morbid obesity cirrhosis alcoholism use illicit drug perform regular physical activity participate another study invasive procedure plan persistent nonadherence therapeutic regimen peak respiratory exchange ratio ( RER ) low 1.00</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Exercise</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Sympathetic Nervous System</keyword>
	<keyword>MicroRNA</keyword>
</DOC>